Can Mounjaro Cause a Water Infection or Urinary Symptoms?

Urinary tract infections (UTIs) are not a recognised or listed side effect of Mounjaro in the UK SmPC or NHS guidance.
Mounjaro can cause gastrointestinal side effects, including nausea and vomiting, which may lead to reduced fluid intake and mild dehydration — a known contributor to urinary symptoms.
Blood sugar changes during early treatment, particularly in people with prediabetes or diabetes, may temporarily affect susceptibility to certain infections.
Any urinary symptoms that are persistent, painful or accompanied by fever warrant prompt review by a GP, regardless of what treatment you are taking.

Urinary tract infections are not listed as a recognised side effect of Mounjaro (tirzepatide) in its UK prescribing information, and clinical trials did not identify them as a concern tied to the medicine. That said, some people on tirzepatide do notice urinary symptoms, and there are indirect reasons worth understanding. These are prescription-only medicines, assessed individually by a clinician before treatment begins. What follows is a factual account of what the evidence actually says, drawing on the NHS tirzepatide medicines page and the published trial data.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What tirzepatide does and doesn't do to the urinary system: a step-by-step look

Step 1 — check whether Mounjaro is actually linked to UTIs in the evidence

The first thing to establish is what the clinical record says. Mounjaro's UK summary of product characteristics lists its known side effects in detail. Urinary tract infections do not appear among them. The large SURMOUNT-1 trial, involving around 2,500 adults over 72 weeks, reported that the most common adverse events were gastrointestinal: nausea, vomiting, diarrhoea and constipation. Water infections were not a signal that emerged from that programme.

That distinction matters. When a medicine is trialled at scale, researchers track every symptom reported, including infections. The absence of a UTI signal in SURMOUNT-1 and the wider tirzepatide programme is meaningful. It is not that the question was overlooked; it was asked and the answer was negative.

If you want to read the full side-effect profile in the language used by regulators, the Mounjaro SmPC on the eMC sets it out clearly. It is the same document your prescriber works from.

Step 2, understand why some people still notice urinary symptoms

Saying a medicine does not directly cause UTIs is not the same as saying urinary symptoms are impossible while taking it. Several indirect mechanisms are worth understanding.

Nausea is one of the most common early side effects of tirzepatide, and it can reduce your appetite for food and fluids alike. Drinking less water than usual concentrates urine and gives bacteria a more hospitable environment in the bladder. This is a well-established pathway to UTIs that has nothing to do with tirzepatide specifically; it applies to any sustained period of low fluid intake.

A second factor applies to people who start Mounjaro with elevated blood sugar. As glucose regulation improves, there can be a transitional phase where sugar in the urine fluctuates. Glucose-rich urine is a better growth medium for bacteria. This is more relevant for people managing type 2 diabetes than for those taking tirzepatide solely for weight management, but it is worth knowing.

You can read more about the relationship between Mounjaro and urine infections on a dedicated page that goes deeper into reported urinary symptoms across the available literature.

Step 3, know what to do if symptoms appear

A burning sensation when urinating, needing to go more frequently, cloudy or strong-smelling urine, or pain in the lower abdomen are the hallmark signs of a UTI. If these develop at any point during tirzepatide treatment, the right first step is to contact your GP or call NHS 111. UTIs are common and very treatable, but they do not improve without attention, and leaving them can allow infection to spread to the kidneys.

Do not assume the symptoms are caused by Mounjaro without talking to a clinician, and equally, do not dismiss them as unrelated simply because UTIs are not a listed side effect. Your prescriber needs the full picture.

Staying well hydrated throughout treatment is one practical step everyone on tirzepatide can take. Keep a water bottle in your gym bag or on the desk if that helps you remember; the specific goal is to avoid the dehydration that GI side effects can quietly cause. Routine hydration is not a substitute for medical advice, but it does reduce one of the indirect risk factors described above.

People who experience recurring UTIs while on any GLP-1 medicine should also ask their prescriber about whether to report the pattern via the MHRA's Yellow Card scheme. That reporting system exists precisely to detect patterns that may not have been visible in the original trial population.

Step 4, other urinary-adjacent questions people ask about Mounjaro

Questions about tirzepatide and urinary symptoms often come bundled with related concerns. Some people ask specifically about whether Mounjaro can cause bladder infections, which is a narrower form of the same question and warrants the same answer: not a recognised effect, but indirect pathways exist. Others are curious about whether Mounjaro causes yeast infections, a separate mechanism involving changes in blood sugar and local pH that our dedicated page explores in full biological context, and again it is not a listed adverse event but a question worth taking seriously. A related concern some people raise is whether tirzepatide can cause a yeast infection, and that page looks at the same question from the perspective of the active ingredient, covering the biological reasons this comes up and what the evidence does and does not support.

If you are weighing up the full side-effect profile of tirzepatide before starting or continuing treatment, our page on Mounjaro OEN covers the dispensing and supply context that often comes up alongside clinical questions. Understanding the range of weight-loss treatment options (including how they compare on tolerability) can also help you have a more informed conversation with a prescriber.

One more point: if you are already on treatment and a symptom is worrying you, our clinical team is available seven days a week through aftercare. You do not need to wait for your next scheduled review. If you have been searching for a direct answer to whether Mounjaro can cause a urine infection, that page brings together the evidence in one place. Check the FAQs for how to reach us, or go straight to our contact page.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions